Antidepressant medicine sales in Belgium are projected to decline significantly from 2024 to 2028. In 2023, the sales stood at 117.3 million Euros. Forecasted sales show a downward trend with the following values: 112.6 million Euros in 2024, 107.9 in 2025, 103.2 in 2026, 98.5 in 2027, and 93.8 in 2028, each expressed in million Euros. This delineates a year-on-year percentage decrease, reflecting a consistent contraction in sales volume. Over the last two years, the sales dropped from 117.3 million Euros in 2023 to 112.6 in 2024. The Compound Annual Growth Rate (CAGR) over these five years indicates an average annual decrease across the forecasted period.

Trends to watch for in the future include:

Impact of new therapies and alternative treatments on market share.
Regulatory changes affecting the availability and price of antidepressant medicines.
Shifts in healthcare policies and insurance coverage.
Rising awareness and stigmatization around mental health impacting demand.